` Comparison: 206650 vs ATXS - Alpha Spread

E
206650
vs
ATXS

Over the past 12 months, EuBiologics Co Ltd has underperformed ATXS, delivering a return of +24% compared to the ATXS's +93 346% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
206650
ATXS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

E
Intrinsic Value
22 106.2 KRW
Undervaluation 34%
Intrinsic Value
Price
ATXS Intrinsic Value
75.09 USD
Overvaluation 99%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
E
EuBiologics Co Ltd
KOSDAQ:206650
14 700 KRW
Astria Therapeutics Inc
NASDAQ:ATXS
5 784.3 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
206650, ATXS

206650
ATXS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
E
EuBiologics Co Ltd
Revenue
Astria Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
206650, ATXS

206650
ATXS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
E
EuBiologics Co Ltd
KOSDAQ:206650
Astria Therapeutics Inc
NASDAQ:ATXS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

EuBiologics Co Ltd
56.4%
ATXS
0%

Operating Margin

EuBiologics Co Ltd
41.4%
ATXS
-19 335.7%

Net Margin

EuBiologics Co Ltd
31.9%
ATXS
-17 568%

FCF Margin

EuBiologics Co Ltd
41.5%
ATXS
-17 042.9%

ROE

EuBiologics Co Ltd
35.1%
ATXS
-43.1%

ROA

EuBiologics Co Ltd
24.6%
ATXS
-39.2%

ROIC

EuBiologics Co Ltd
39.2%
ATXS
-462.1%

ROCE

EuBiologics Co Ltd
38.9%
ATXS
-45.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
206650, ATXS

Loading
206650
ATXS
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
206650, ATXS

Loading
206650
ATXS
Difference
www.alphaspread.com

Performance By Year
206650, ATXS

Loading
206650
ATXS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 206650 to other stocks
PNEXF
Pharnext SCA
More expensive
vs EuBiologics Co Ltd
ABBV
Abbvie Inc
More expensive
vs EuBiologics Co Ltd
AMGN
Amgen Inc
More expensive
vs EuBiologics Co Ltd
GILD
Gilead Sciences Inc
More expensive
vs EuBiologics Co Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett